Article info
Therapeutics
Systematic review and meta-analysis
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events
- Correspondence to Swapnil N Rajpathak
US Outcomes Research, Merck, 351 N Sumneytown Pike, UG2MW-05, North Wales, PA 19454, USA; swapnil.rajpathak{at}merck.com
Citation
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events
Publication history
- First published September 26, 2011.
Online issue publication
March 24, 2012
Article Versions
- Previous version (26 September 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions